Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
CF102 Phase II liver cancer trial
.
Show all posts
Showing posts with label
CF102 Phase II liver cancer trial
.
Show all posts
Wednesday, March 4, 2015
Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial
›
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and i...
›
Home
View web version
